Skip navigation
Skip navigation

Opioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current

Faber, Elizabeth (Louise); Sah, Pankaj

Description

Pyramidal neurons in the lateral amygdala discharge trains of action potentials that show marked spike frequency adaptation, which is primarily mediated by activation of a slow calcium-activated potassium current. We show here that these neurons also express an α-dendrotoxin- and tityustoxin-Kα-sensitive voltage-dependent potassium current that plays a key role in the control of spike discharge frequency. This current is selectively targeted to the primary apical dendrite of these neurons....[Show more]

dc.contributor.authorFaber, Elizabeth (Louise)
dc.contributor.authorSah, Pankaj
dc.date.accessioned2015-12-13T22:51:00Z
dc.date.available2015-12-13T22:51:00Z
dc.identifier.issn0270-6474
dc.identifier.urihttp://hdl.handle.net/1885/81063
dc.description.abstractPyramidal neurons in the lateral amygdala discharge trains of action potentials that show marked spike frequency adaptation, which is primarily mediated by activation of a slow calcium-activated potassium current. We show here that these neurons also express an α-dendrotoxin- and tityustoxin-Kα-sensitive voltage-dependent potassium current that plays a key role in the control of spike discharge frequency. This current is selectively targeted to the primary apical dendrite of these neurons. Activation of μ-opioid receptors by application of morphine or D-Ala 2-N-Me-Phe4-Glycol5-enkephalin (DAMGO) potentiates spike frequency adaptation by enhancing the α -dendrotoxin-sensitive potassium current. The effects of μ-opioid agonists on spike frequency adaptation were blocked by inhibiting G-proteins with N-ethylmaleimide (NEM) and by blocking phospholipase A2. Application of arachidonic acid mimicked the actions of DAMGO or morphine. These results show that μ-opioid receptor activation enhances spike frequency adaptation in lateral amygdala neurons by modulating a voltage-dependent potassium channel containing Kv1.2 subunits, through activation of the phospholipase A 2-arachidonic acid-lipoxygenases cascade.
dc.publisherSociety for Neuroscience
dc.sourceJournal of Neuroscience
dc.subjectKeywords: arachidonic acid; calcium activated potassium channel; dendrotoxin; enkephalin[2 dextro alanine 4 methylphenylalanine 5 glycine]; guanine nucleotide binding protein; lipoxygenase; morphine; mu opiate receptor; mu opiate receptor agonist; n ethylmaleimide; Anxiolytic; Arachidonic; Channel; Kv1.2; Lipoxygenase; Nociception; Pain
dc.titleOpioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current
dc.typeJournal article
local.description.notesImported from ARIES
local.description.refereedYes
local.identifier.citationvolume24
dc.date.issued2004
local.identifier.absfor110903 - Central Nervous System
local.identifier.ariespublicationMigratedxPub9392
local.type.statusPublished Version
local.contributor.affiliationFaber, Elizabeth (Louise), College of Medicine, Biology and Environment, ANU
local.contributor.affiliationSah, Pankaj, College of Medicine, Biology and Environment, ANU
local.bibliographicCitation.issue12
local.bibliographicCitation.startpage3031
local.bibliographicCitation.lastpage3039
local.identifier.doi10.1523/JNEUROSCI.4496-03.2004
dc.date.updated2015-12-11T10:43:24Z
local.identifier.scopusID2-s2.0-1642505790
CollectionsANU Research Publications

Download

There are no files associated with this item.


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator